Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2151640016 | Clindamycin 1% gel (product) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 2159398017 | Clindamycin 1% gel | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 2553443013 | Clindamycin phosphate 1% gel | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 2673110018 | Clindamycin 10mg/mL gel | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 3693001015 | Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram conventional release cutaneous gel (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3693002010 | Clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3693003017 | Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram conventional release cutaneous gel | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel | Is a | Clindamycin only product in cutaneous dose form | true | Inferred relationship | Some | ||
| Clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Some | ||
| Clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel | Is a | Clindamycin in topical dosage form | false | Inferred relationship | Some | ||
| Clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel | Has active ingredient | Clindamycin | false | Inferred relationship | Some | ||
| Clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
| Clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Some | ||
| Clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel | Has manufactured dose form | Cutaneous gel | true | Inferred relationship | Some | ||
| Clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel | Has BoSS | Clindamycin | true | Inferred relationship | Some | 1 | |
| Clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel | Has concentration strength numerator value | 10 | false | Inferred relationship | Some | 1 | |
| Clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel | Has precise active ingredient | Clindamycin phosphate | true | Inferred relationship | Some | 1 | |
| Clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
FHIR